510(k) Report

FDA applicant

Roche Diagnostics Operations (Rdo)

Indianapolis, IN14 decisions2014–20204 recalls

FDA records 14 decisions for Roche Diagnostics Operations (Rdo) (Indianapolis, IN) from 2014 to 2020: 14 510(k) clearances. Most are in product codes PDJ (Hemoglobin A1c Test System) and DKB (Calibrators, Drug Mixture). Its devices cite 14 predicates, 0 of them its own earlier devices. 4 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Roche Diagnostics Operations (Rdo)’s devices, and how often a recall has named them.

FDA decisions per year

2in 2020

2014: 22015: 22016: 52017: 12018: 12019: 12020: 2
2014high 5 (2016) · low 0 (2021)2026

2026 so far, outlined.

Recalls per year

1in 2024

2019: 32024: 1
2014high 3 (2019) · low 0 (2014)2026

Class I Class II/III not classified

FIG. 1 — Roche Diagnostics Operations (Rdo) by year, 2014–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Roche Diagnostics Operations (Rdo)’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Roche”

FDA records each applicant name separately; these may or may not be the same firm.